This review comprehensively presents recent research on SFN, elucidates its mechanism of action, and discusses potential therapeutic benefits for eye disorders such as age‐related macular degeneration (AMD), diabetic retinopathy (DR), cataracts, and other ophthalmic diseases. This evidence concerns the gene SFN and diabetic retinopathy.